Beroni Group, an Australia-based biopharmaceutical enterprise, has signed a Memorandum of Understanding with tella, Inc. to collaborate in the field of immunotherapy for cancer treatment.
Contract development and manufacturing organization (CDMO) Hovione announced it has re-joined the membership of the Instituto de Biologia Experimental e Tecnológica (iBET). In 1989, Hovione was a founding member of iBET.